PlexusDx Precision Peptide Genetic Test examines GLP1R and GIPR variants that may contextualize your dose requirements
While these trials have provided encouraging early signals regarding tolerability, the evidence base remains limited compared to fully approved medicines
The trial showed statistically and clinically significant weight loss for both doses of tesofensine compared to a placebo, meeting its primary objective
Cost comparison example: Standard protocol (12 months total): 12 months $1,000 = $12,000
In trials, people taking retatrutide lost an average of 24% of their body weight over 48 weeks, compared to around 15-17% with Wegovy (semaglutide) and 15-22% with Mounjaro (tirzepatide)
In a separate systematic review and meta-analysis, pharmacist interventions were compared with usual care and found to significantly reduce HbA1c levels by 0.85% (95% CI: 1.06 to 0.65